Surgery Partners (SGRY) Projected to Release Quarterly Earnings on Monday

Surgery Partners (NASDAQ:SGRY) is expected to issue its Q2 2026 results before the market opens on Monday, August 10th. Analysts expect Surgery Partners to post earnings of $0.0579 per share and revenue of $830.03 million for the quarter. Investors are encouraged to explore the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Monday, August 10, 2026 at 8:30 AM ET.

Surgery Partners Stock Performance

NASDAQ:SGRY opened at $15.53 on Friday. The company has a debt-to-equity ratio of 1.17, a quick ratio of 1.69 and a current ratio of 1.86. The stock has a market capitalization of $2.03 billion, a P/E ratio of -25.88, a PEG ratio of 4.64 and a beta of 1.91. The company has a 50 day moving average price of $15.43 and a 200 day moving average price of $14.44. Surgery Partners has a fifty-two week low of $11.41 and a fifty-two week high of $24.10.

Wall Street Analyst Weigh In

SGRY has been the topic of a number of research analyst reports. Zacks Research raised Surgery Partners from a “hold” rating to a “strong-buy” rating in a research report on Thursday, June 4th. Jefferies Financial Group restated a “buy” rating and set a $17.00 price target on shares of Surgery Partners in a research report on Wednesday, May 6th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Surgery Partners in a research note on Tuesday, May 26th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Surgery Partners has an average rating of “Moderate Buy” and a consensus target price of $21.60.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the business. Caitong International Asset Management Co. Ltd lifted its holdings in Surgery Partners by 45,640.0% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 2,287 shares of the company’s stock worth $49,000 after buying an additional 2,282 shares in the last quarter. PNC Financial Services Group Inc. grew its stake in shares of Surgery Partners by 128.4% in the third quarter. PNC Financial Services Group Inc. now owns 2,702 shares of the company’s stock worth $58,000 after acquiring an additional 1,519 shares in the last quarter. Aquatic Capital Management LLC acquired a new position in shares of Surgery Partners in the third quarter worth $121,000. Tower Research Capital LLC TRC increased its position in shares of Surgery Partners by 68.7% during the second quarter. Tower Research Capital LLC TRC now owns 9,313 shares of the company’s stock worth $207,000 after acquiring an additional 3,794 shares during the period. Finally, Prudential Financial Inc. purchased a new stake in shares of Surgery Partners during the second quarter worth $219,000.

About Surgery Partners

Surgery Partners, Inc operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.

Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care.